Neurotechnology Market 2024-2032: Share, Outlook, Demand, Scope and Growth Opportunities

IMARC Group’s report titled “Neurotechnology Market Report by Product Type (Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants), End User (Hospitals, Clinics, Diagnostic Centres, Ambulatory Surgical Centres), and Region 2024-2032“. The global neurotechnology market size reached US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.2 Billion by 2032, exhibiting a growth rate (CAGR) of 10.54% during 2024-2032.

Factors Affecting the Growth of the Neurotechnology Industry:

• Advancements in Neuroscience and Technology:

The ongoing progress in neuroscience and technology is leading to significant breakthroughs, particularly in the development of brain-computer interfaces (BCIs), neural prosthetics, neurostimulation devices, and neurofeedback systems. These innovations are revolutionizing the field of neurotechnology, pushing its boundaries beyond the conventional. BCIs enable direct communication channels between the brain and external devices, presenting revolutionary solutions for individuals with paralysis or severe motor impairments. Additionally, neural prosthetics are rapidly advancing to restore lost functionalities caused by injury or illness. Furthermore, neurostimulation devices such as deep brain stimulators are offering new possibilities for conditions like Parkinson’s disease and major depression, greatly enhancing patient outcomes.

• Increasing Prevalence of Neurological Disorders:

The increasing prevalence of neurological disorders like Alzheimer’s, Parkinson’s, epilepsy, and depression is having a significant impact on healthcare systems and driving the need for more advanced neurotechnological solutions. These conditions, which affect millions of people, pose considerable challenges for those affected, their families, and the wider healthcare infrastructure. Due to the complexity of these disorders, new and creative approaches are necessary for effective management and treatment. Neurotechnology holds great promise in this area by providing sophisticated tools for precise diagnosis, real-time monitoring, and successful treatment. Additionally, advancements such as cutting-edge imaging technology, neurotherapeutic devices, and personalized medicine strategies are revolutionizing how these conditions are managed. These innovations offer a sense of optimism for better quality of life, improved patient outcomes, and potential cures in the future.

• Rising Investment in Research & Development:

The field of neurotechnology is attracting substantial investment in research and development (R&D) from both public and private sources. This financial support plays a vital role in driving innovation and moving revolutionary research from labs to real-world applications. Moreover, these investments are opening up new horizons in neuroscience, leading to the creation of advanced technologies and treatments that have the potential to revolutionize healthcare. The funding helps in uncovering new therapies and diagnostic methods while also improving existing neurotechnological tools to make them more efficient, accessible, and user-friendly.

Leading Companies Operating in the Global Neurotechnology Industry:

• Allengers Medical Systems Ltd
• Canon Medical Systems Corporation (Canon Inc.)
• Elekta Solutions AB
• GE HealthCare Technologies Inc. (General Electric)
• Koninklijke Philips N.V.
• Natus Medical Incorporated, Shimadzu Corporation
• Siemens Healthcare GmbH (Siemens AG)
• The Magstim Company Limited
• Tristan Technologies Inc..

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/neurotechnology-market/requestsample

Neurotechnology Market Report Segmentation:

By Product Type:

Product Type Insights:

• Imaging Modalities
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
• Neurostimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Transcranial Direct Current Stimulation (TDCS)
• Cranial Surface Measurement
  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
• Neurological Implants

Imaging modalities dominate the market due to their essential role in diagnosing and monitoring neurological disorders, driving demand from healthcare providers and researchers alike. 

By End Users:

End User Insights:

• Hospitals
• Clinics
• Diagnostic Centres
• Ambulatory Surgical Centres

Hospitals account for the largest market share owing to the widespread adoption of neurotechnologies to improve patient care and treatment outcomes.

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Global Neurotechnology Market Trends:

Currently, the advancement of Brain-Computer Interfaces (BCIs) is fueling progress in neurotechnology, facilitating direct interaction between the brain and external devices. This technology is utilized across various sectors such as healthcare, gaming, and accessibility. Additionally, neuroimaging methods like MRI, EEG, and fNIRS are evolving to provide a deeper insight into brain functions and activities. These tools play a vital role in clinical as well as research environments. Furthermore, neurotechnology plays a significant role in healthcare by aiding in the diagnosis, treatment, and recovery of neurological conditions like Parkinson’s disease, epilepsy, and strokes. This includes the use of neurostimulation devices, neuromodulation therapies, and neurofeedback systems. Moreover, there is a growing demand for wearable neurodevices that can monitor real-time brain activity for applications in wellness programs, sports training optimization, and mental health monitoring.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163